Who has invested in Strongbridge Biopharma?

Cantor Fitzgerald & Co. are named among the investors backing Strongbridge Biopharma.

Strongbridge Biopharma Funding: $197M Raised, Growth (2018)

Strongbridge Biopharma funding overview

Strongbridge Biopharma is based in San Francisco. Strongbridge Biopharma has raised $197M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Growth announced in January 2018. The round record for Strongbridge Biopharma runs through 2018; nothing later has been disclosed. Investors on record include Cantor Fitzgerald & Co..

Strongbridge Biopharma at a glance

Total raised: $197M
Latest round: Growth
Latest round date: January 2018
Headquarters: San Francisco
Notable investors: Cantor Fitzgerald & Co.

Frequently asked about Strongbridge Biopharma funding

How much has Strongbridge Biopharma raised?: Strongbridge Biopharma has raised $197M in total disclosed funding across the rounds on record.
Who has invested in Strongbridge Biopharma?: Cantor Fitzgerald & Co. are named among the investors backing Strongbridge Biopharma.
What was the latest Strongbridge Biopharma funding round?: The most recent disclosed round is a Growth, announced in January 2018.
Where is Strongbridge Biopharma based?: Strongbridge Biopharma is based in San Francisco.
When did Strongbridge Biopharma last raise?: The last disclosed Strongbridge Biopharma round closed in January 2018 at Growth.

Totals shown for Strongbridge Biopharma aggregate every disclosed round on file. To see how that compares, browse the companies in San Francisco and the investors behind them below.

Strongbridge Biopharma Funding: $197M Raised, Growth (2018)

Strongbridge Biopharma funding overview

Strongbridge Biopharma at a glance

Frequently asked about Strongbridge Biopharma funding

Companies related to Strongbridge Biopharma (18)

Browse related funding lists (5)